Clinical Trial Update: Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose aspirin given every 12 hours in patients undergoing coronary artery bypass grafting and/or aortic valve surgery. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Centro Cardiologico Monzino | Conditions: Coronary Arteriosclerosis | Phase 2 | Status: UNKNOWN